Secondary hyperparathyroidism (SHPT) is elevation of parathyroid hormone (PTH) secondary to hypocalcemia.
PTH maintains calcium homeostasis by acting on the renal tubules, on calcium stores in the skeletal system, and indirectly on the gastrointestinal tract through activation of vitamin D and enteral absorption.
The disease most frequently associated with SHPT is chronic kidney disease. However, the most common reason for SHPT is vitamin D deficiency. Inadequate vitamin D stores are common in older people, those with malabsorption syndromes, or those with limited exposure to sunlight.
Management includes appropriate treatment of the underlying cause and vitamin D supplementation. Parathyroidectomy is infrequently required to remove irreversibly enlarged parathyroid glands in an effort to restore normal parathyroid physiology.
Untreated, it can result in significant skeletal and cardiovascular complications, which contribute to overall morbidity and mortality.
Any disorder that results in hypocalcemia will elevate parathyroid hormone levels and can serve as a cause of secondary hyperparathyroidism (SHPT). The most frequent causes are chronic kidney disease (CKD), malabsorption syndromes, and chronic inadequate sunlight exposure, acting via alterations in vitamin D, phosphorus, and calcium.
SHPT is a complication of CKD and is important in the pathogenesis of CKD-mineral bone disorder (MBD). CKD-MBD is defined as a systemic disorder of mineral and bone metabolism due to CKD manifested by either one or a combination of the following: abnormalities of calcium, phosphorus, PTH, or vitamin D metabolism; abnormalities in bone turnover, mineralization, volume, linear growth, or strength; vascular or other soft tissue calcification.
History and exam
Key diagnostic factors
- features of chronic kidney disease
- features of underlying malabsorption syndrome
Other diagnostic factors
- muscle cramps and bone pain
- perioral tingling or paresthesia in fingers or toes
- Chvostek sign
- Trousseau sign
- bowed legs or knock knees
- chronic kidney disease
- vitamin D deficiency: inadequate sunlight exposure
- nutritional deficiency (especially absence of dairy products and fish)
- vitamin D deficiency: malabsorption
- vitamin D deficiency: hepatic dysfunction
- vitamin D deficiency: genetic disorder
- vitamin D deficiency: obesity
- medication use
1st investigations to order
- serum calcium
- serum intact parathyroid hormone (iPTH)
- serum creatinine
- serum BUN
Investigations to consider
- serum phosphorus
- serum 25-hydroxyvitamin D
- serum magnesium
- ultrasound neck
- sestamibi scan
- high-resolution contrast CT scan neck and upper chest
- MRI neck and upper chest
lack of sunlight
CKD stages 3 to 5D
- Primary hyperparathyroidism
- Evaluation, treatment, and prevention of vitamin D deficiency
- Dietary reference intakes for calcium and vitamin D
- Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer